Continuous Glucose Monitoring – References

Andrew P. Koutnik

Current: Principal Investigator & Research Faculty Institute for Sports Science and Medicine Department of Health, Nutrition, and Food Sciences College of Education, Health, and Human Sciences Florida State University; Visiting Research Scientist Human Healthspan, Resilience, and Performance Florida Institute for Human and Machine Cognition

Past: Principal Investigator, Research Scientist, Samsun Diabetes Research Institute, Principal Investigator, Research Scientist, Human Healthspan, Resilience and Performance, Florida Institute for Human and Machine Cognition, Presidential Fellow, University of South Florida Morsani College of Medicine, Department of Molecular Pharmacology & Physiology, Honor Medallion and Bess Ward Honor Awardee, Florida State University; Department of Biomedical Sciences, College of Medicine; Department of Exercise Science, College of Health and Human Sciences, Affiliate, Help a Diabetes Help a Diabetic Child. Research and Therapeutic Outreach.

Dr. Andrew P. Koutnik, Ph.D. is an award-winning research scientist recognized for his leadership in diabetes and chronic disease research

References

Continuous Glucose Monitoring – References

  1. Inoue K, Liu M, Aggarwal R, Marinacci LX, Wadhera RK. Prevalence and Control of Diabetes Among US Adults, 2013 to 2023. JAMA 2025.
  2. In: Cowie CC, Casagrande SS, Menke A, et al., eds. Diabetes in America. 3rd ed. Bethesda (MD); 2018.
  3. Echouffo-Tcheugui JB, Selvin E. Prediabetes and What It Means: The Epidemiological Evidence. Annu Rev Public Health 2021; 42: 59-77.
  4. Organization WH. Obesity and overweight, 2025.
  5. Prevention CfDCa. National Diabetes Statistics Report. Atlanta, GA; 2022.
  6. Hirsch IB. Introduction: History of Glucose Monitoring.  Role of Continuous Glucose Monitoring in Diabetes Treatment. Arlington (VA); 2018: 1.
  7. Didyuk O, Econom N, Guardia A, Livingston K, Klueh U. Continuous Glucose Monitoring Devices: Past, Present, and Future Focus on the History and Evolution of Technological Innovation. J Diabetes Sci Technol 2021; 15(3): 676-83.
  8. Battelino T, Alexander CM, Amiel SA, et al. Continuous glucose monitoring and metrics for clinical trials: an international consensus statement. Lancet Diabetes Endocrinol 2023; 11(1): 42-57.
  9. Prins PJ, Noakes TD, Buga A, et al. Low and High Carbohydrate Isocaloric Diets on Performance, Fat Oxidation, Glucose and Cardiometabolic Health in Middle Age Athletes. Front Nutr 2023.
  10. Noakes TD, D’Agostino DP, Volek JS, Prins PJ, Koutnik AP. The effect of the low-carbohydrate high-fat (LCHF) diet on the crossover point during exercise of increasing intensity. Front Physiology 2023.
  11. Keshet A, Shilo S, Godneva A, et al. CGMap: Characterizing continuous glucose monitor data in thousands of non-diabetic individuals. Cell Metab 2023; 35(5): 758-69 e3.
  12. Shilo S, Keshet A, Rossman H, et al. Continuous glucose monitoring and intrapersonal variability in fasting glucose. Nat Med 2024; 30(5): 1424-31.
  13. Kruger DF, Anderson JE. Continuous Glucose Monitoring (CGM) Is a Tool, Not a Reward: Unjustified Insurance Coverage Criteria Limit Access to CGM. Diabetes Technol Ther 2021; 23(S3): S45-S55.
  14. Pratley RE, Kanapka LG, Rickels MR, et al. Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial. JAMA 2020; 323(23): 2397-406.
  15. van Beers CAJ, DeVries JH, Kleijer SJ, et al. Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial. The Lancet Diabetes & Endocrinology 2016; 4(11): 893-902.
  16. MILLER E, BRANDNER L, WRIGHT E, JR. 84-LB: HbA1c Reduction after Initiation of the FreeStyle Libre System in Type 2 Diabetes Patients on Long-Acting Insulin or Noninsulin Therapy. Diabetes 2020; 69(Supplement_1).
  17. WRIGHT E, JR., KERR MSD, REYES IJ, NABUTOVSKY Y, MILLER E. 78-LB: HbA1c Reduction Associated with a FreeStyle Libre System in People with Type 2 Diabetes Not on Bolus Insulin Therapy. Diabetes 2020; 69(Supplement_1).
  18. Holzer R, Bloch W, Brinkmann C. Continuous Glucose Monitoring in Healthy Adults-Possible Applications in Health Care, Wellness, and Sports. Sensors (Basel, Switzerland) 2022; 22(5).
  19. Teo E, Hassan N, Tam W, Koh S. Effectiveness of continuous glucose monitoring in maintaining glycaemic control among people with type 1 diabetes mellitus: a systematic review of randomised controlled trials and meta-analysis. Diabetologia 2022; 65(4): 604-19.
  20. Garg SK, Kipnes M, Castorino K, et al. Accuracy and Safety of Dexcom G7 Continuous Glucose Monitoring in Adults with Diabetes. Diabetes Technol Ther 2022; 24(6): 373-80.
  21. Oser TK, Cucuzzella M, Stasinopoulos M, Moncrief M, McCall A, Cox DJ. An Innovative, Paradigm-Shifting Lifestyle Intervention to Reduce Glucose Excursions With the Use of Continuous Glucose Monitoring to Educate, Motivate, and Activate Adults With Newly Diagnosed Type 2 Diabetes: Pilot Feasibility Study. JMIR Diabetes 2022; 7(1): e34465.
  22. Wing RR, Phelan S. Long-term weight loss maintenance. Am J Clin Nutr 2005; 82(1 Suppl): 222s-5s.
  23. Casal S, DellaValle N, Mittone L, Soraperra I. Feedback and efficient behavior. PLoS One 2017; 12(4): e0175738.
  24. Barnard KD, Kropff J, Choudhary P, et al. Acceptability of Implantable Continuous Glucose Monitoring Sensor. J Diabetes Sci Technol 2018; 12(3): 634-8.
  25. Cook SW, Berrenberg JL. Approaches to encouraging conservation behavior: A review and conceptual framework. Journal of Social Issues 1981; 37(2): 73-107.
  26. Bilodeau EA, Bilodeau IM. Variable frequency of knowledge of results and the learning of a simple skill. J Exp Psychol 1958; 55(4): 379-83.
  27. Goldenberg JZ, Day A, Brinkworth GD, et al. Efficacy and safety of low and very low carbohydrate diets for type 2 diabetes remission: systematic review and meta-analysis of published and unpublished randomized trial data. BMJ 2021; 372: m4743.
  28. Buchanan L, Calkins M, Kalayjian T, et al. TOWARD, a metabolic health intervention, demonstrates robust 1-year weight loss and cost-savings through deprescription. Front Nutr 2025; 12: 1548609.
  29. Skroce K, Zignoli A, Fontana FY, et al. Real World Interstitial Glucose Profiles of a Large Cohort of Physically Active Men and Women. Sensors (Basel) 2024; 24(3).
  30. Bowler AM, Whitfield J, Marshall L, Coffey VG, Burke LM, Cox GR. The Use of Continuous Glucose Monitors in Sport: Possible Applications and Considerations. Int J Sport Nutr Exerc Metab 2023; 33(2): 121-32.
  31. Riddell MC, Turner LV, Patton SR. Is There an Optimal Time of Day for Exercise? A Commentary on When to Exercise for People Living With Type 1 or Type 2 Diabetes. Diabetes Spectr 2023; 36(2): 146-50.
  32. Liao Y, Basen-Engquist KM, Urbauer DL, Bevers TB, Hawk E, Schembre SM. Using Continuous Glucose Monitoring to Motivate Physical Activity in Overweight and Obese Adults: A Pilot Study. Cancer Epidemiology Biomarkers & Prevention 2020; 29(4): 761.
  33. Liao Y, Schembre S. Acceptability of Continuous Glucose Monitoring in Free-Living Healthy Individuals: Implications for the Use of Wearable Biosensors in Diet and Physical Activity Research. JMIR Mhealth Uhealth 2018; 6(10): e11181.
  34. Manov AE, Chauhan S, Dhillon G, et al. The Effectiveness of Continuous Glucose Monitoring Devices in Managing Uncontrolled Diabetes Mellitus: A Retrospective Study. Cureus 2023; 15(7): e42545.
  35. Bergenstal RM, Beck RW, Close KL, et al. Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring. Diabetes Care 2018; 41(11): 2275-80.
  36. Valenzano M, Cibrario Bertolotti I, Valenzano A, Grassi G. Time in range-A1c hemoglobin relationship in continuous glucose monitoring of type 1 diabetes: a real-world study. BMJ Open Diabetes Res Care 2021; 9(1).
  37. Hirsch IB, Welsh JB, Calhoun P, Puhr S, Walker TC, Price DA. Associations between HbA(1c) and continuous glucose monitoring-derived glycaemic variables. Diabet Med 2019; 36(12): 1637-42.
  38. Chehregosha H, Khamseh ME, Malek M, Hosseinpanah F, Ismail-Beigi F. A View Beyond HbA1c: Role of Continuous Glucose Monitoring. Diabetes Ther 2019; 10(3): 853-63.
  39. Beyond ACWG. Need for Regulatory Change to Incorporate Beyond A1C Glycemic Metrics. Diabetes Care 2018; 41(6): e92-e4.

Related topics